Let's be honest: the Pap smear has had a great run. For more than 50 years, it served as the backbone of cervical cancer prevention, and it worked. Cervical cancer incidence and deaths fell by more than 50% in the U.S., largely because of it. But the era of the Pap as the go-to screening test is ending. Primary HPV testing is here, and it is transforming women's healthcare.
A wave of landmark changes, including FDA approvals, updated guidelines, and new self-collection options, has transformed how cervical cancer screening can be done. And for women in perimenopause and menopause, this shift couldn't come at a better time. The speculum doesn't have to be the gatekeeper to your cervical health anymore.
First, What Is HPV?
HPV (human papillomavirus) is the most common sexually transmitted infection in the world. It spreads through intimate skin-to-skin contact, not just intercourse. Condoms lower the risk but don't eliminate it. Most sexually active people, roughly 8 in 10, will have HPV at some point in their lives, and most never know it.
There are more than 200 types of HPV. Most are harmless, and a few cause genital warts. About a dozen are considered "high-risk" because they can cause cancer. Two of them, HPV 16 and 18, are responsible for about 70% of cervical cancers.
Here's the reassuring part: your immune system clears about 90% of HPV infections on its own within two years. The problem is the infection that doesn't clear. When a high-risk type hangs around for years (what we call a persistent infection), it can slowly change the cells of the cervix. Left undetected, those changes can progress to cancer, usually over a decade or more.
And one thing I want every woman to hear: a positive HPV result is not a sign that you or your partner did anything wrong. HPV can stay quiet in the body for years, even decades, and become detectable again later. Testing positive in midlife, even after a long monogamous relationship, is common. It is a virus doing what viruses do.
Why Did Screening Change to Test for HPV Instead of Looking for Abnormal Cells?
A Pap smear looks at cervical cells under a microscope to find changes that have already happened. An HPV test looks for the cause: the high-risk virus itself, often years before any cell change.
That makes HPV testing more sensitive at catching women at risk. It also means a negative result gives you longer-lasting reassurance. If no high-risk HPV is there, your chance of developing cervical cancer in the next several years is very low. That is why the yearly Pap is no longer recommended for cervical cancer screening and HPV screening is.
It's also why self-collection works. HPV doesn't live only on the cervix. It infects the whole lower genital tract, so a swab of the vagina picks up the virus just as reliably as a sample scraped from the cervix. We don't need to see your cervix to find HPV. We just need a good sample.
What Is Self-Collection HPV Testing?
Self-collection HPV testing lets you collect your own vaginal sample. No speculum, no stirrups, no uncomfortable exam. Using a simple swab (similar in feel to inserting a tampon), you collect cells from your vagina, and the sample is then sent to a lab to test for high-risk strains of human papillomavirus (HPV), the virus responsible for virtually all cases of cervical cancer.
This isn't experimental. It's FDA-approved, clinically validated, and backed by some of the most respected medical organizations in the country, including the American College of Obstetricians and Gynecologists and the American Cancer Society.
The Science Is Clear: It Works
Studies have consistently shown that self-collected vaginal specimens are just as accurate as clinician-collected cervical specimens for detecting high-risk HPV. Currently, about one in four American women is not up to date with cervical cancer screening. And here is the sobering reality: about half of all cervical cancer diagnoses occur in women who have either never been screened or haven't been screened recently.
A Moment of Historic Change: What's New in Guidelines
The past two years have brought a rapid evolution in recommendations:
May 2024 — FDA Approval of In-Office Self-Collection. The FDA expanded approvals to allow patients to self-collect vaginal samples in a clinical setting, such as a doctor's office, urgent care, pharmacy, or mobile clinic. For the first time, a pelvic exam was no longer required to get screened.
February 2025 — Clinical Practice Guidelines Released. A collaboration of 19 national organizations, led by ASCCP, published the first-ever clinical guidelines for managing self-collected HPV results. If results are negative (approximately 90% of cases), re-testing is recommended in three years. Positive results for HPV 16 or 18 — the most aggressive strains — warrant direct referral for colposcopy (an office procedure where a trained clinician looks at your cervix with a specialized microscope).
December 2025 — American Cancer Society Updates Guidelines. ACS updated its cervical cancer screening guidelines to formally include self-collection as an option for average-risk women ages 25–65, recommending primary HPV testing every five years if done by your doctor or every three years with self-collection.
January 2026 — HRSA Updates Federal Guidance. The Health Resources and Services Administration issued updated federal guidance stating that women ages 30–65 at average risk can receive a high-risk HPV test every five years — by clinician-collected or self-collected sample — as the preferred screening approach. Pap smears remain available but are no longer the preferred method for this age group. HRSA's guidelines are what require most plans to cover screening with no cost-sharing.
Why This Is Especially Important for Women in Perimenopause and Menopause
As a menopause specialist and OB/GYN, I see this shift as a game-changer for our patients at MyMenopauseRx — and here's why.
Many perimenopausal and menopausal women fall off the screening schedule. Outside of peak reproductive years, women often see their OB/GYN less frequently. Life gets busy. The uncomfortable exam gets put off. This is precisely why mortality rates from cervical cancer are disproportionately higher in older women. Those cancers tend to be more advanced at diagnosis because screening didn't happen.
Vaginal atrophy due to genitourinary syndrome of menopause (GSM) can make pelvic exams genuinely painful. The hormonal changes of menopause affect vaginal tissue, making speculum exams more uncomfortable than they once were. Self-collection eliminates this barrier entirely.
Trauma and anxiety around pelvic exams are real. For women with a history of trauma, the speculum exam can be a significant source of distress. Having an alternative that is private, comfortable, and self-directed respects bodily autonomy in a meaningful way.
What Does Self-Collection at the Lab Actually Involve?
If you can insert a tampon, you can do this. It's that simple. At the lab, you'll get a collection kit with a long, thin swab (a soft-tipped stick). You'll go into a private room. Nobody watches, nobody assists, and there are no stirrups. After washing your hands and getting into a comfortable position, you'll gently insert the swab into your vagina. Most swabs have a marking that shows you how far to go. You'll rotate the swab for an amount of time as instructed on the kit, usually several seconds, and then remove the swab and finish as your kit directs.
Telehealth makes it seamless. After your virtual well-woman visit, you'll take the order to a Quest Diagnostics location near you. You collect your own sample there, privately, with no pelvic exam and no speculum. The HPV test is typically covered by insurance with no cost-sharing, and you never have to come into a doctor's office for screening. Your results get sent to your MyMenopauseRx OB/GYN or NP, who will review them and determine your next screening interval or whether you need an in-person exam.
What to Know Before You Self-Collect
Self-collection is appropriate for average-risk women ages 25–65 with no current symptoms or concerns. It is not recommended if you:
- Have abnormal vaginal bleeding or discharge
- Have had a recent abnormal HPV or Pap test result
- Are immunocompromised or on immunosuppressive medications
For those women, clinician-collected cervical sampling remains the appropriate path. I always like to remind women that a positive HPV result is not a cancer diagnosis and not a reason for panic. It is a signal for follow-up testing with your in-person gynecologist.
The Bottom Line
We have an opportunity to essentially eliminate cervical cancer as a cause of death in this country. We have an effective vaccine. We have highly accurate screening. And now, we have a screening option that removes the most common reasons women don't get tested.
At MyMenopauseRx, we believe that well-woman care doesn't stop at menopause — it evolves. Our Annual Well-Woman Virtual Visits include cervical cancer screening as part of what we offer, including guidance on self-collection HPV testing for eligible patients, because you deserve healthcare that meets you where you are.
Have questions about cervical cancer screening or what's right for you? Book a virtual visit with our team at MyMenopauseRx — because your well-woman care should be as modern as you are.
This article is for educational purposes only and not meant to provide or replace your medical care.
